Key facts
- Suzhou Yuanfeng Capital Management is a other based in Suzhou, Jiangsu with 10 tracked portfolio companies.
- Notable positions include Megarobo, Elite Robot, Geneplus Technology, Aprinoia Therapeutics, Tyligand Bioscience.
About Suzhou Yuanfeng Capital Management
Suzhou Yuanfeng Capital Management is an economic development agency based in Suzhou, China. Established in 2020, the agency specializes in venture capital and industrial investment. It supports innovation in biotech, pharmaceuticals, and advanced manufacturing. The assets are managed by the executive team.
Free account
See the whole book
- ·Watchlist + alerts for Suzhou Yuanfeng Capital Management's activity
Create free account
No card required
Portfolio, priced
10 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Megarobo | — | $1.3B | — | |
| Elite Robot | — | $1.2B | — | |
| Geneplus Technology | — | $604.6M | — | |
| Aprinoia Therapeutics | — | $295.5M | — | |
| Tyligand Bioscience | — | $222.2M | — | |
| Fulinlan | — | — | — | |
| Denglin Technology | Application Specific Semiconductors | — | — | |
| Lungshield Medical | — | — | — | |
| Coherent Biopharma | — | — | — | |
| Synthgene | — | — | — |
Frequently asked
- What companies does Suzhou Yuanfeng Capital Management invest in?
- Suzhou Yuanfeng Capital Management has 10 recorded portfolio companies, including Megarobo, Elite Robot, Geneplus Technology, Aprinoia Therapeutics.